Regulatory Risk Assessment of Pharmaceuticals in the Environment: Current Practice and Future Priorities.
Chemical regulation
ecological risk assessment
pharmaceuticals
species sensitivity distributions
Journal
Environmental toxicology and chemistry
ISSN: 1552-8618
Titre abrégé: Environ Toxicol Chem
Pays: United States
ID NLM: 8308958
Informations de publication
Date de publication:
09 Dec 2022
09 Dec 2022
Historique:
revised:
25
07
2022
received:
01
06
2022
accepted:
29
11
2022
pubmed:
10
12
2022
medline:
10
12
2022
entrez:
9
12
2022
Statut:
aheadofprint
Résumé
How can data on the occurrence of pharmaceuticals and personal care products (PPCPs) in the environment and the quality of ecosystems exposed to PPCPs be used to determine whether current regulatory risk assessment schemes are effective? This is one of 20 "big questions" concerning PPCPs in the environment posed in a landmark review paper in 2012. Ten years later, we review the developments around this question, focusing on the first P in PPCPs, that is, pharmaceuticals, or more specifically the active ingredients included in them (active pharmaceutical ingredients, APIs). We illustrate how extensive data on both the occurrence of APIs and the ecotoxicological sensitivity of aquatic species to them can be used in a retrospective risk assessment. In the Netherlands, current regulatory risk assessment schemes offer insufficient protection against direct ecotoxicological effects from APIs: the toxic pressure exerted by the 39 APIs included in our study exceeds the policy-related protective threshold of 0.05 (the "95%-protection level") in at least 13% of sampled surface waters. In general, anti-inflammatory and antirheumatic products (e.g., diclofenac, ibuprofen) contributed most to the overall toxic pressure, followed by sex hormones and modulators of the genital system (e.g., ethinylestradiol) and psychoanaleptics (e.g., caffeine). We formulated three open questions for future research. The first relates to improving the availability and accessibility of good-quality ecotoxicity data on pharmaceuticals for the global scientific, regulatory, and general public. The second relates to the adaptation of regulatory risk assessment frameworks for developing regions of the world. The third relates to the integration of effect-based and ecological approaches into regulatory risk assessment practice. Environ Toxicol Chem 2023;00:1-12. © 2022 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2022 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.
Références
Abt, E., Rodricks, J. V., Levy, J. I., Zeise, L., & Burke, T. A. (2010). Science and decisions: Advancing risk assessment. Risk Analysis, 30(7), 1028-1036. https://doi.org/10.1111/j.1539-6924.2010.01426.x
Ågerstrand, M., Berg, C., Björlenius, B., Breitholtz, M., Brunström, B., Fick, J., Gunnarsson, L., Larsson, D. G. J., Sumpter, J. P., Tysklind, M., & Rudén, C. (2015). Improving environmental risk assessment of human pharmaceuticals. Environmental Science & Technology, 49(9), 5336-5345. https://doi.org/10.1021/acs.est.5b00302
Altenburger, R., Brack, W., Burgess, R. M., Busch, W., Escher, B. I., Focks, A., Mark Hewitt, L., Jacobsen, B. N., de Alda, M. L., Ait-Aissa, S., Backhaus, T., Ginebreda, A., Hilscherová, K., Hollender, J., Hollert, H., Neale, P. A., Schulze, T., Schymanski, E. L., Teodorovic, I., & Krauss, M. (2019). Future water quality monitoring: Improving the balance between exposure and toxicity assessments of real-world pollutant mixtures. Environmental Sciences Europe, 31(1), 12. https://doi.org/10.1186/s12302-019-0193-1
Antweiler, R. C. (2015). Evaluation of statistical treatments of left-censored environmental data using coincident uncensored data sets. II. Group comparisons. Environmental Science & Technology, 49(22), 13439-13446. https://doi.org/10.1021/acs.est.5b02385
aus der Beek, T., Weber, F.-A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., & Küster, A. (2016). Pharmaceuticals in the environment-Global occurrences and perspectives. Environmental Toxicology and Chemistry, 35(4), 823-835. https://doi.org/10.1002/etc.3339
Bouzas-Monroy, A., Wilkinson, J. L., Melling, M., & Boxall, A. B. A. (2022). Assessment of the potential ecotoxicological effects of pharmaceuticals in the world's rivers. Environmental Toxicology and Chemistry, 41(8), 2008-2020. https://doi.org/10.1002/etc.5355
Boxall, A., Rudd, M. A., Brooks, B. W., Caldwell, D. J., Choi, K., Hickmann, S., Innes, E., Ostapyk, K., Staveley, J. P., & Verslycke, T. (2012). Pharmaceuticals and personal care products in the environment: What are the big questions? Environmental Health Perspectives, 120(9), 1221-1229.
Constantine, L. A., Green, J. W., & Schneider, S. Z. (2020). Ibuprofen: Fish short-term reproduction assay with zebrafish (Danio rerio) based on an extended OECD 229 protocol. Environmental Toxicology and Chemistry, 39(8), 1534-1545. https://doi.org/10.1002/etc.4742
Daughton, C. G. (2014). The Matthew Effect and widely prescribed pharmaceuticals lacking environmental monitoring: Case study of an exposure-assessment vulnerability. Science of the Total Environment, 466-467, 315-325. https://doi.org/10.1016/j.scitotenv.2013.06.111
Douziech, M., van Zelm, R., Oldenkamp, R., Franco, A., Hendriks, A. J., King, H., & Huijbregts, M. A. J. (2018). Estimation of chemical emissions from down-the-drain consumer products using consumer survey data at a country and wastewater treatment plant level. Chemosphere, 193, 32-41. https://doi.org/10.1016/j.chemosphere.2017.11.009
Escher, B., Neale, P., & Leusch, F. (2021). Bioanalytical tools in water quality assessment. IWA Publishing. https://doi.org/10.2166/9781789061987
Escher, B. I., Aїt-Aїssa, S., Behnisch, P. A., Brack, W., Brion, F., Brouwer, A., Buchinger, S., Crawford, S. E., du Pasquier, D., Hamers, T., Hettwer, K., Hilscherová, K., Hollert, H., Kase, R., Kienle, C., Tindall, A. J., Tuerk, J., van der Oost, R., Vermeirssen, E., & Neale, P. A. (2018). Effect-based trigger values for in vitro and in vivo bioassays performed on surface water extracts supporting the environmental quality standards (EQS) of the European Water Framework Directive. Science of the Total Environment, 628-629, 748-765. https://doi.org/10.1016/j.scitotenv.2018.01.340
Escher, B. I., & Neale, P. A. (2021). Effect-based trigger values for mixtures of chemicals in surface water detected with in vitro bioassays. Environmental Toxicology and Chemistry, 40(2), 487-499. https://doi.org/10.1002/etc.4944
European Commission. (2018). Technical guidance for deriving environmental quality standards (Guidance Document No. 27-Update version 2018).
Fabrega, J., & Carapeto, R. (2020). Regulatory review of the environmental risk assessment of veterinary medicinal products in the European Union, with particular focus on the centralised authorisation procedure. Environmental Sciences Europe, 32(1), 99. https://doi.org/10.1186/s12302-020-00374-x
Finckh, S., Beckers, L.-M., Busch, W., Carmona, E., Dulio, V., Kramer, L., Krauss, M., Posthuma, L., Schulze, T., Slootweg, J., von der Ohe, P. C., & Brack, W. (2022). A risk based assessment approach for chemical mixtures from wastewater treatment plant effluents. Environment International, 164, 107234. https://doi.org/10.1016/j.envint.2022.107234
González Peña, O. I., López Zavala, M. Á., & Cabral Ruelas, H. (2021). Pharmaceuticals market, consumption trends and disease incidence are not driving the pharmaceutical research on water and wastewater. International Journal of Environmental Research and Public Health, 18(5), 2532. https://doi.org/10.3390/ijerph18052532
Hamers, T., Legler, J., Blaha, L., Hylland, K., Marigomez, I., Schipper, C. A., Segner, H., Vethaak, A. D., Witters, H., de Zwart, D., & Leonards, P. E. G. (2013). Expert opinion on toxicity profiling-report from a NORMAN expert group meeting. Integrated Environmental Assessment and Management, 9(2), 185-191. https://doi.org/10.1002/ieam.1395
Harris, C. A., Scott, A. P., Johnson, A. C., Panter, G. H., Sheahan, D., Roberts, M., & Sumpter, J. P. (2014). Principles of sound ecotoxicology. Environmental Science and Technology, 48(6), 3100-3111. https://doi.org/10.1021/es4047507
Inohana, S., Kaminishi, M., de Roode, D. F., & Minami, H. (2019, June 26-28). Comparison of environmental risk assessment scheme on pharmaceuticals between EU and Japan, [Poster presentation; P-174] Japanese Society of Toxicology, Tokushima, Japan.
Ji, K., Liu, X., Lee, S., Kang, S., Kho, Y., Giesy, J. P., & Choi, K. (2013). Effects of non-steroidal anti-inflammatory drugs on hormones and genes of the hypothalamic-pituitary-gonad axis, and reproduction of zebrafish. Journal of Hazardous Materials, 254-255(1), 242-251. https://doi.org/10.1016/j.jhazmat.2013.03.036
Jose, J., Sandra Pinto, J., Kotian, B., Mathew Thomas, A., & Narayana Charyulu, R. (2020). Comparison of the regulatory outline of ecopharmacovigilance of pharmaceuticals in Europe, USA, Japan and Australia. Science of the Total Environment, 709, 134815. https://doi.org/10.1016/j.scitotenv.2019.134815
Kar, S., Sanderson, H., Roy, K., Benfenati, E., & Leszczynski, J. (2020). Ecotoxicological assessment of pharmaceuticals and personal care products using predictive toxicology approaches. Green Chemistry, 22(5), 1458-1516. https://doi.org/10.1039/c9gc03265g
Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R. (2020). Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: An analysis of pharmaceutical sales data. The Lancet Infectious Diseases, 21, 107-115. https://doi.org/10.1016/S1473-3099(20)30332-7
Kookana, R. S., Williams, M., Boxall, A. B. A., Larsson, D. G. J., Gaw, S., Choi, K., Yamamoto, H., Thatikonda, S., Zhu, Y.-G., & Carriquiriborde, P. (2014). Potential ecological footprints of active pharmaceutical ingredients: An examination of risk factors in low-, middle- and high-income countries. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 369(1656), 20130586. http://rstb.royalsocietypublishing.org/content/369/1656/20130586.abstract
Lee, D., & Choi, K. (2019). Comparison of regulatory frameworks of environmental risk assessments for human pharmaceuticals in EU, USA, and Canada. Science of the Total Environment, 671, 1026-1036. https://doi.org/10.1016/j.scitotenv.2019.03.372
Leverett, D., Merrington, G., Crane, M., Ryan, J., & Wilson, I. (2021). Environmental quality standards for diclofenac derived under the European Water Framework Directive: 1. Aquatic organisms. Environmental Sciences Europe, 33(1), 133. https://doi.org/10.1186/s12302-021-00574-z
Maack, G., Äystö, L., Carere, M., Clausen, H., James, A., Junghans, M., Junttila, V., Hollender, J., Marinov, D., Stroomberg, G., Triebskorn, R., Verbruggen, E., & Lettieri, T. (2022). Comment on environmental quality standards for diclofenac derived under the European Water Framework Directive: 1. Aquatic organisms. Environmental Sciences Europe, 34(1), 24. https://doi.org/10.1186/s12302-022-00599-y
Ministry of Health, Labour and Welfare. (2016). Guidance on the environmental risk assessment in new drug development. Japan. https://www.pmda.go.jp/files/000214195.pdf
Oelkers, K. (2021). Is the objective of the Water Framework Directive to deal with pollutant emissions at source coherently implemented by the EU's substance-specific legal acts? A comparison of the environmental risk control of pharmaceutical legislation with the REACH-, Biocidal Products- and Plant Protection Products Regulation. Sustainable Chemistry and Pharmacy, 20, 100386. https://doi.org/10.1016/j.scp.2021.100386
Oelkers, K., & Floeter, C. (2019). The accessibility of data on environmental risk assessment of pharmaceuticals: Is the marketing authorisation procedure in conflict with the international right of access to environmental information? Environmental Sciences Europe, 31(1), 58. https://doi.org/10.1186/s12302-019-0256-3
Oldenkamp, R., Hendriks, H. W. M., van de Meent, D., & Ragas, A. M. J. (2015). Hierarchical Bayesian approach to reduce uncertainty in the aquatic effect assessment of realistic chemical mixtures. Environmental Science and Technology, 49(17), 10457-10465. https://doi.org/10.1021/acs.est.5b02651
Oldenkamp, R., Hoeks, S., Čengić, M., Barbarossa, V., Burns, E. E., Boxall, A. B. A., & Ragas, A. M. J. (2018). A high-resolution spatial model to predict exposure to pharmaceuticals in European surface waters: EPiE. Environmental Science and Technology, 52(21), 12494-12503. https://doi.org/10.1021/acs.est.8b03862
Posthuma, L., de Zwart, D., & Dyer, S. D. (2019). Chemical mixtures affect freshwater species assemblages: From problems to solutions. Current Opinion in Environmental Science & Health, 11, 78-89. https://doi.org/10.1016/j.coesh.2019.09.002
Posthuma, L., van Gils, J., Zijp, M. C., van de Meent, D., & de Zwartd, D. (2019). Species sensitivity distributions for use in environmental protection, assessment, and management of aquatic ecosystems for 12 386 chemicals. Environmental Toxicology and Chemistry, 38(4), 703-711. https://doi.org/10.1002/etc.4373
Postma, J., Keijzers, R., Slootweg, J., & Posthuma, L. (2021). Toxiciteit van Nederlands oppervlaktewater in de jaren 2013-2018. STOWA.
Rijkswaterstaat. (2015). Richtlijn Stedelijk Afvalwater EU2015 WFS. Retrieved April 29, 2022 from: https://www.nationaalgeoregister.nl/geonetwork/srv/dut/catalog.search#/metadata/280cee65-1b66-4973-a569-75122e0b745b
Schwarz, S., Gildemeister, D., Hein, A., Schröder, P., & Bachmann, J. (2021). Environmental fate and effects assessment of human pharmaceuticals: Lessons learnt from regulatory data. Environmental Sciences Europe, 33(1), 68. https://doi.org/10.1186/s12302-021-00503-0
Sebestyén, I., Monostory, K., & Hirka, G. (2018). Environmental risk assessment of human and veterinary medicinal products-Challenges and ways of improvement. Microchemical Journal, 136, 67-70. https://doi.org/10.1016/j.microc.2017.08.012
South, A. (2022). rnaturalearth: World map data from natural earth. https://docs.ropensci.org/rnaturalearth (website). https://github.com/ropensci/rnaturalearth
Umwelt Bundesamt. (2021). Database-Pharmaceuticals in the environment. https://www.umweltbundesamt.de/en/database-pharmaceuticals-in-the-environment-0
van der Oost, R., Beyer, J., & Vermeulen, N. P. E. (2003). Fish bioaccumulation and biomarkers in environmental risk assessment: A review. Environmental Toxicology and Pharmacology, 13(2), 57-149. https://doi.org/10.1016/S1382-6689(02)00126-6
van der Oost, R., Sileno, G., Suárez-Muñoz, M., Nguyen, M. T., Besselink, H., & Brouwer, A. (2017). SIMONI (smart integrated monitoring) as a novel bioanalytical strategy for water quality assessment: Part I-Model design and effect-based trigger values. Environmental Toxicology and Chemistry, 36(9), 2385-2399. https://doi.org/10.1002/etc.3836
van Dijk, J., Gustavsson, M., Dekker, S. C., & van Wezel, A. P. (2021). Towards “one substance - one assessment”: An analysis of EU chemical registration and aquatic risk assessment frameworks. Journal of Environmental Management. 280, 111692. https://doi.org/10.1016/j.jenvman.2020.111692
Vissers, M., Vergouwen, L., Witteveen, S., Derksen, A., & Raadgever, T. (2017). Landelijke hotspotanalyse geneesmiddelen RWZI's (STOWA Report 42/2017, Stowa Rapport;2017-42). STOWA. https://edepot.wur.nl/429440
Whomsley, R., Brendler-Schwaab, S., Griffin, E., Jensen, J., Moermond, C., Scholz, B., Nilssen, L. S., Stemplewski, H., & Roennefahrt, I. (2019). Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use. Environmental Sciences Europe, 31(1), 17. https://doi.org/10.1186/s12302-019-0198-9
Wilkinson, J. L., Boxall, A. B. A., Kolpin, D. W., Leung, K. M. Y., Lai, R. W. S., Galbán-Malagón, C., Adell, A. D., Mondon, J., Metian, M., Marchant, R. A., Bouzas-Monroy, A., Cuni-Sanchez, A., Coors, A., Carriquiriborde, P., Rojo, M., Gordon, C., Cara, M., Moermond, M., Luarte, T., & Teta, C. (2022). Pharmaceutical pollution of the world's rivers. Proceedings of the National Academy of Sciences, 119(8), e2113947119. https://doi.org/10.1073/pnas.2113947119
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., Bouwman, J., Brookes, A. J., Clark, T., Crosas, M., Dillo, I., Dumon, O., Edmunds, S., Evelo, C. T., Finkers, R., & Mons, B. (2016). The FAIR guiding principles for scientific data management and stewardship. Scientific Data, 3, 160018. https://doi.org/10.1038/sdata.2016.18
World Health Organisation. (2022). ATC classification index with DDDs.